Revised 12 June 2013​

There are no effective means of screening for pancreatic cancer or ampullary cancer at this time.

​Screening with EUS or MRI may be indicated in high risk patients including first degree relatives of patients with genetic predisposition to pancreatic carcinoma, carriers of BRCA2 mutations, p16 mutations and patients with Lynch Syndrome with affected first degree relatives, or patients with Peutz-Jeghers syndrome.